arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Jasper Therapeutics, Inc.

JSPR

$0.70 ▲ +0.05 (+8.44%) at close

28 Visible periods

21 Metrics

Absolute Benchmarks

Price Chart

Health

Fair

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Jasper Therapeutics, Inc. shows weak fundamentals, weighed down by Return on Invested Capital. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $20.1M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -254.5% ↗

FCF / Share $-0.51

Trailing P/E —

Price / Book 5.8x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

28-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-1.17M

↑ +94.5% —

FCF / Share Free cash flow per share

$-0.51

↑ +66.6% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -1596.4% is weak on an absolute basis (target > 10%)

Health Breakdown

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q3 FY2018 Mar 31, 2018 10-Q ↗
EPS Growth YoY (%)	97.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	8.9% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-79.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-36.9% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-9.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-675.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-546.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-543.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	84.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	48.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	94.5% Excellent ↑ Excellent Improving Year-over-year change in net income	62.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-0.5% Weak ↑ Weak Improving Year-over-year change in net income	-83.2% Weak ↓ Weak Declining Year-over-year change in net income	-54.7% Weak ↓ Weak Declining Year-over-year change in net income	-46.7% Weak ↓ Weak Declining Year-over-year change in net income	-30.7% Weak ↓ Weak Declining Year-over-year change in net income	-2.3% Weak ↑ Weak Improving Year-over-year change in net income	3.7% Caution ↑ Caution Improving Year-over-year change in net income	-25.5% Weak ↑ Weak Improving Year-over-year change in net income	-546.1% Weak ↓ Weak Declining Year-over-year change in net income	-546.1% Weak ↓ Weak Declining Year-over-year change in net income	-546.1% Weak ↓ Weak Declining Year-over-year change in net income	-45.9% Weak ↓ Weak Declining Year-over-year change in net income	77.4% Excellent ↑ Excellent Improving Year-over-year change in net income	38.2% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	83.0% Excellent ↓ Excellent Declining Year-over-year change in net income	-4748.1% Weak ↓ Weak Declining Year-over-year change in net income	-1165.5% Weak ↑ Weak Improving Year-over-year change in net income	14048.8% Excellent Excellent Year-over-year change in net income	—	-20019.1% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	66.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-28.9% Weak Weak Year-over-year change in free cash flow	—	—	—	-906.6% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q3 FY2018 Mar 31, 2018 10-Q ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	3.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	59.8% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
FCF / Net Income (x)	12.39x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	2.40x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.15x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	4.24x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	6.44x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	1.61x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	-0.06x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.10x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	-5.99x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q3 FY2018 Mar 31, 2018 10-Q ↗
Return on Invested Capital (%)	-254.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-301.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-130.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-91.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-40.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-32.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	-10.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	13.4% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	-3.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-51.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-44.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-33.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-58.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-37.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-31.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-14.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-15.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-9.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-0.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-0.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-0.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-34.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-330%)	-219.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1562%)	-161.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1179%)	-113.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-858%)	-50.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-435%)	-39.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-363%)	-22.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-248%)	-14.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-197%)	-12.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-181%)	-21.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-241%)	-15.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-201%)	-12.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-186%)	-11.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-36.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-345%)	-4.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-131%)	-3.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-125%)	-3.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-122%)	-13.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	-12.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-71.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-576%)	110.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+633%)	151.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+912%)	-4.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-127%)	-5.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	0.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-95%)	—	-4.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-128%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q3 FY2018 Mar 31, 2018 10-Q ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	-163.55x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-199.24x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-292.49x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-3987.67x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-177.47x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-1119.89x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-331.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—
Net Debt (USD)	$-14.14M	$-28.69M	$-50.90M	$-39.51M	$-48.80M	$-71.64M	$-92.50M	$-106.82M	$-118.47M	$-86.89M	$-103.87M	$-115.81M	$-129.40M	$-38.25M	$-50.95M	—	$-70.40M	$-84.70M	$-100.91M	$-309.73K	$-590.61K	$-19.84M	$-757.52K	$-914.25K	$-1.06M	$-1.21M	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q3 FY2018 Mar 31, 2018 10-Q ↗
Basic EPS, GAAP (USD)	$-0.04	$0.23	$-1.13	$-1.74	$-1.41	$-1.64	$-1.24	$-0.97	$-1.03	$-1.50	$-0.16	$-0.15	$-0.16	$-9.66	$-0.32	$-0.29	—	$4.44	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.51	—	$-1.02	$-1.01	$-1.52	—	—	—	$-1.18	—	—	—	$-0.12	—	—	$-0.26	—	—	—	—	—	—	—	—	—	—	—	—
Dividend per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.04
Book Value per Share (USD)	$0.12	$0.15	$0.41	$1.45	$2.81	$4.11	$5.58	$6.64	$7.51	$7.03	$0.85	$0.99	$1.14	$9.46	$1.25	$1.61	$1.80	$1.84	$2.08	—	—	$-12.68	$6.79	—	—	$7.23	—	—
Tangible Book Value per Share (USD)	$0.12	$0.15	$0.41	$1.45	$2.81	$4.11	$5.58	$6.64	$7.51	$7.03	$0.85	$0.99	$1.14	$9.46	$1.25	$1.61	$1.80	$1.84	$2.08	—	—	$-12.68	$6.79	—	—	$7.23	—	—
Basic Weighted Avg Shares (shares)	28.67M	—	16.64M	15.33M	15.02M	—	15.00M	14.99M	13.33M	—	109.72M	109.21M	88.16M	—	36.57M	36.40M	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q3 FY2018 Mar 31, 2018 10-Q ↗
Working Capital (USD)	$11.30M	$21.45M	$33.52M	$22.47M	$40.84M	$60.57M	$82.35M	$98.61M	$111.39M	$76.56M	$93.31M	$109.59M	$124.62M	$34.67M	$44.99M	—	$67.83M	$79.81M	$93.25M	$94.00K	$576.03K	$16.67M	$783.16K	$923.06K	$1.22M	$1.43M	—	—
Total Equity (USD)	$3.40M	$4.15M	$11.57M	$23.50M	$42.24M	$61.67M	$83.68M	$100.31M	$113.23M	$78.44M	$94.13M	$110.20M	$125.20M	$35.99M	$47.56M	$58.78M	$68.11M	$69.52M	$78.60M	$5.00M	$5.00M	$-35.13M	$5.00M	$5.00M	$5.00M	$5.00M	$24.00K	—

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q3 FY2018 Mar 31, 2018 10-Q ↗
Depreciation Expense (USD)	$21.00K	—	—	—	—	—	—	—	—	—	$300.00K	—	—	$273.00K	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-1.17M	$-9.10M	$-18.74M	$-26.72M	$-21.24M	$-24.32M	$-18.64M	$-14.58M	$-13.73M	$-16.58M	$-14.26M	$-14.26M	$-14.26M	$-13.21M	$-2.21M	$-2.21M	$-2.21M	$-9.06M	$-9.75M	$-3.57M	$5.50M	$-53.35M	$-201.19K	$-282.06K	$38.86K	—	$-1.00K	—
Operating Cash Flow (USD)	$-14.55M	$-21.87M	$-17.00M	$-15.45M	$-22.84M	$-21.13M	—	—	$-15.74M	$-16.48M	—	—	$-10.34M	$-12.65M	—	$-9.36M	$-14.21M	$-14.58M	—	—	$-317.75K	$-5.39M	—	—	$-232.87K	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 28 quarters

Jasper Therapeutics, Inc.

Analytical Summary

28-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare JSPR with peers